Seattle Children's Hospital Research Foundation

Seattle, Washington 98105

1 studies enrolling now · 8 studies all time

What they study most

Adolescent, CNS Malignancies, Child, Infantile Fibrosarcoma, Infantile Myofibromatosis, Medullary Thyroid Cancer, Muscular Dystrophy, Duchenne, Neoplasm Metastasis, Neoplasms, Papillary Thyroid Cancer, Pediatric Solid Tumor, Recurrent Tumor

Studies at this site

• A Master Protocol (LY900023) That Includes Several Clinical Trials of Drugs for Children and Young Adults With Cancer — Recruiting now
• A Study of Oral LOXO-292 (Selpercatinib) in Pediatric Participants With Advanced Solid or Primary Central Nervous System (CNS) Tumors — Running, not enrolling
• A Study of Mirikizumab (LY3074828) in Children and Teenagers With Ulcerative Colitis (UC) — Completed
• CAMPFIRE: A Study of Ramucirumab (LY3009806) in Children and Young Adults With Synovial Sarcoma — Stopped early
• A Study of Dulaglutide (LY2189265) in Children and Adolescents With Type 2 Diabetes — Completed
• A Study of Ramucirumab (LY3009806) in Children With Refractory Solid Tumors — Completed
• A Study of Olaratumab Alone and in Combination With Standard Chemotherapies in Children With Cancer — Completed
• A Study of Tadalafil for Duchenne Muscular Dystrophy — Stopped early